Online First »

HHS Analysis Finds Medicare Paid Claims for Deceased Beneficiaries

According to a report from the Office of the Inspector General (OIG) of the Department of Health and Human Services, Medicare's prescription program kept paying for costly medications even after patients were deceased.


Online Exclusive »

FDA Panel Votes in Favor of Edoxaban Approval

After an FDA advisory panel previously called for limited use of edoxaban for atrial fibrillation (AF), the panel ultimately voted in favor of edoxaban for the prevention of stroke and non–central-nervous-system systemic embolism in patients with nonvalvular AF. The FDA is expected to make a final decision in the next few months, and if approved, this would be the fourth novel anticoagulant for the treatment of AF.


Current Issue

Cover Story; American Academy of Pain Management »

States, Federal Government Debate Use of Medical Marijuana

Phoenix—As a clinical pharmacy specialist at the Stratton Veterans Affairs Medical Center in Albany, New York, Jeffrey Fudin, PharmD, is prohibited from prescribing or dispensing marijuana. He is a federal government employee and must abide by US law that makes marijuana illegal.